.Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AK01_EpinephrineAndOtherDrugs.EpinephrineAndOtherDrugs .Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AK01_EpinephrineAndOtherDrugs.EpinephrineAndOtherDrugs| name: | EpinephrineAndOtherDrugsForObstructiveAirwayDiseases | |
| ATC code: | R03AK01 | |
| route: | inhalation | |
| compartments: | 1 | |
| dosage: | 0.5 | mg |
| volume of distribution: | 2.2 | L |
| clearance: | 800 | mL/min |
| other parameters in model implementation | ||
This combination drug is used as a bronchodilator for the treatment of obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Epinephrine acts as a non-selective adrenergic agonist, causing bronchodilation and relief of bronchospasm. The combination is intended for acute management of bronchoconstrictive episodes. There are limited available modern fixed-dose combinations with this specific ATC, and such combinations are not widely used or approved in current clinical guidelines.
Pharmacokinetic parameters are estimated based on general epinephrine inhalation data in healthy adults; no published population-specific PK studies were found for R03AK01 fixed-dose combinations.